Standard Biotools (LAB) Income from Continuing Operations (2010 - 2026)
Standard Biotools (LAB) posted quarterly Income from Continuing Operations of 14626000.0 for Q1 2026, up 37.47% year-over-year from 10639696.26 in Q1 2025, and down 270.78% quarter-over-quarter from 8564000.0 in Q4 2025.
Standard Biotools (LAB) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Income from Continuing Operations for 17 consecutive years, with 14626000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 37.47% year-over-year to 14626000.0; the TTM figure through Mar 2026 stood at 55444000.0 (down 76.29% YoY), while the FY2025 annual figure was 64207000.0, down 162.25% from the prior year.
- Income from Continuing Operations eased to 14626000.0 in Q1 2026 per LAB's latest filing, from 8564000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 153196000.0 in Q4 2022 and bottomed at 76288000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 10346882.35 across 5 years, with a median of 21047000.0 in 2023.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 305.96% — and 2024, when it surged 178.09%.
- Standard Biotools' Income from Continuing Operations stood at 153196000.0 in 2022, then tumbled by 90.78% to 14126000.0 in 2023, then soared by 178.09% to 39283000.0 in 2024, then tumbled by 78.2% to 8564000.0 in 2025, then slumped by 270.78% to 14626000.0 in 2026.
- Business Quant data shows LAB's Income from Continuing Operations at 14626000.0 in Q1 2026, 8564000.0 in Q4 2025, and 31700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Standard Biotools | 256.97 Mn | -219.75 Mn | 10.54 Mn | -21.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.54 Mn |
| Mar 31, 2026 | -14.63 Mn |
| Dec 31, 2025 | 8.56 Mn |
| Sep 30, 2025 | -31.70 Mn |
| Jun 30, 2025 | -17.68 Mn |
| Mar 31, 2025 | -23.39 Mn |
| Dec 31, 2024 | 39.28 Mn |
| Sep 30, 2024 | -21.90 Mn |
| Jun 30, 2024 | -25.44 Mn |
| Mar 31, 2024 | -32.13 Mn |
| Dec 31, 2023 | 14.13 Mn |
| Sep 30, 2023 | -21.05 Mn |
| Jun 30, 2023 | -17.04 Mn |
| Mar 31, 2023 | -16.84 Mn |
| Dec 31, 2022 | 153.20 Mn |
| Sep 30, 2022 | -29.43 Mn |
| Jun 30, 2022 | -63.55 Mn |
| Mar 31, 2022 | -76.29 Mn |
| Sep 30, 2021 | -49.82 Mn |
| Jun 30, 2021 | -35.95 Mn |